No. | Analyte | Method | LLOQ (ng/mL) | Note |
1 |
11-Deoxycortisol |
HPLC/MS/MS |
0,02 |
determination of endogenous levels in postmenopausal women |
2 |
17-Carboxybudesonide |
HPLC/MS/MS |
0,1 |
in dog plasma |
3 |
17-Deacetylnorgestimate |
HPLC/MS/MS |
0,02 |
|
4 |
17-Hydroxyprogesterone |
HPLC/MS/MS |
0,02 |
determination of endogenous levels in postmenopausal women |
5 |
1-Adamantylethyloxy-3-morpholino-2-propanol |
HPLC/MS/MS |
0,05 |
|
6 |
2-Hydroxymethylmetronidazole |
HPLC/MS/MS |
4 |
|
7 |
5'-Deoxy-5-fluorocytidine |
HPLC/MS/MS |
25 |
|
8 |
5'-Deoxy-5-fluorouridine |
HPLC/MS/MS |
25 |
|
9 |
5-Fluorouracil |
HPLC/MS/MS |
5 |
|
10 |
5-Hydroxymethyltolterodine |
HPLC/MS/MS |
0,05 |
|
11 |
5-Hydroxypropafenone |
HPLC/MS/MS |
0,5 |
|
12 |
9-Hydroxyrisperidone |
HPLC/MS/MS |
0,1 |
|
13 |
Abiraterone |
HPLC/MS/MS |
0,2 |
|
14 |
Acetaminophen (paracetamol) |
HPLC/MS/MS |
250 |
|
15 |
Acetazolamide |
HPLC/MS/MS |
250 |
|
16 |
Acetylcysteine |
HPLC/MS/MS |
50 |
|
17 |
Acetylsalicylic acid |
HPLC/MS/MS |
25 |
common method with salicylic acid |
18 |
Acetylsalicylic acid |
HPLC/MS/MS |
5 |
common method with salicylic acid |
19 |
Aciclovir |
HPLC |
15 |
|
20 |
Aciclovir |
HPLC/MS/MS |
5 |
|
21 |
Agomelatine |
HPLC/MS/MS |
0,1 |
|
22 |
Aldosterone |
HPLC/MS/MS |
0,01 |
determination of endogenous levels in postmenopausal women |
23 |
Alendronate |
HPLC/MS/MS |
0,75 |
|
24 |
Amlodipine |
HPLC/MS/MS |
0,1 |
|
25 |
Amlodipine |
HPLC/MS/MS |
0,5 |
rat plasma direct injection |
26 |
Amlodipine |
chiral HPLC/MS/MS |
0,2 |
|
27 |
Amoxicillin |
HPLC/MS/MS |
100 |
|
28 |
Anagrelide |
HPLC/MS/MS |
0,075 |
|
29 |
Anastrozole |
HPLC/MS/MS |
0,5 |
|
30 |
Androstenedione |
HPLC/MS/MS |
0,02 |
determination of endogenous levels in postmenopausal women |
31 |
Aripiprazene |
HPLC/MS/MS |
0,1 |
|
32 |
Aripiprazole |
HPLC/MS/MS |
0,4 |
|
33 |
Atomoxetine |
HPLC/MS/MS |
5 |
|
34 |
Atorvastatin |
HPLC/MS/MS |
0,8 |
common method with ezetimibe |
35 |
Atorvastatin |
HPLC/MS/MS |
0,5 |
|
36 |
Atorvastatin |
HPLC/MS/MS |
0,25 |
common method with Ezetimibe and Ezetimibe Glucuronide |
37 |
Azithromycin |
HPLC/MS/MS |
4 |
|
38 |
Bendroflumethiazide |
HPLC/MS/MS |
0,4 |
|
39 |
Bicalutamide |
chiral HPLC/MS/MS |
1 |
|
40 |
Bicalutamide |
HPLC/MS/MS |
2 |
|
41 |
Bisoprolol |
HPLC/MS/MS |
0,5 |
|
42 |
Bosentan |
HPLC/MS/MS |
5 |
|
43 |
Budesonide |
HPLC/MS/MS |
0,05 |
in dog plasma |
44 |
Bumetanide |
HPLC |
4 |
|
45 |
Caffeine |
HPLC/MS/MS |
100 |
common method with paraxantine |
46 |
Candesartan |
HPLC/MS/MS |
2 |
|
47 |
Capecitabine |
HPLC/MS/MS |
100 |
|
48 |
Captopril (free) |
HPLC/MS/MS |
1 |
|
49 |
Captopril (free) |
HPLC |
15 |
|
50 |
Carbamazepine |
HPLC |
25 |
|
51 |
Carbocisteine |
HPLC/MS/MS |
50 |
|
52 |
Carvedilol |
HPLC/MS/MS |
1 |
|
53 |
Carvedilol metabolite M IV |
HPLC/MS/MS |
0,2 |
|
54 |
Cefditoren |
HPLC/MS/MS |
50 |
|
55 |
Cefixime |
HPLC/MS/MS |
100 |
|
56 |
Cefprozil |
HPLC/MS/MS |
100 |
|
57 |
Cefuroxime |
HPLC/MS/MS |
50 |
|
58 |
Celecoxib |
HPLC/MS/MS |
10 |
|
59 |
Chlorambucil |
HPLC/MS/MS |
1 |
|
60 |
Chlorthalidone |
HPLC/MS/MS |
2 |
|
61 |
Cilostazol |
HPLC/MS/MS |
50 |
|
62 |
Ciprofloxacine |
HPLC/MS/MS |
50 |
|
63 |
Clarithromycin |
HPLC/MS/MS |
50 |
|
64 |
Clobazam |
HPLC/MS/MS |
1 |
|
65 |
Clozapin |
GC/MS |
0,6 |
|
66 |
C-peptide |
ELISA |
0,2 |
|
67 |
Dapagliflozin |
HPLC/MS/MS |
2 |
common method with linagliptin |
68 |
Darunavir |
HPLC/MS/MS |
200 |
|
69 |
Dasatinib |
HPLC/MS/MS |
0,25 |
|
70 |
Desethyloxybutynin |
GC/MS |
2 |
|
71 |
Desethyloxybutynin |
HPLC |
4 |
|
72 |
Desloratadine |
HPLC/MS/MS |
0,05 |
|
73 |
Desmethylfluoxetine |
GC/MS |
0,4 |
|
74 |
Dexamethasone |
HPLC/MS/MS |
0,25 |
|
75 |
Dexketoprofen |
HPLC/MS/MS |
50 |
|
76 |
Dextromethorphan |
HPLC/MS/MS |
0,01 |
|
77 |
Diclofenac |
HPLC/MS/MS |
5 |
|
78 |
Didanosine |
HPLC/MS/MS |
20 |
|
79 |
Dienogest |
HPLC/MS/MS |
1 |
|
80 |
Diosmetin-3-O-glucuronide |
HPLC/MS/MS |
0,05 |
|
81 |
Donepezil |
HPLC/MS/MS |
0,2 |
|
82 |
Doxazosin |
HPLC |
0,4 |
|
83 |
Doxylamine |
HPLC/MS/MS |
|
|
84 |
Drospirenone |
HPLC/MS/MS |
0,5 |
|
85 |
Drotaverine |
HPLC/MS/MS |
3 |
|
86 |
Duloxetine |
HPLC/MS/MS |
0,5 |
|
87 |
Dutasteride |
HPLC/MS/MS |
0,05 |
|
88 |
Emoxipine |
HPLC/MS/MS |
5 |
|
89 |
Enalapril |
HPLC/MS/MS |
1 |
|
90 |
Enalaprilat |
HPLC/MS/MS |
1,2 |
|
91 |
Entecavir |
HPLC/MS/MS |
0,05 |
|
92 |
Eplerenon |
HPLC/MS/MS |
10 |
|
93 |
Epoxycarbamazepin |
HPLC |
25 |
|
94 |
Erlotinib |
HPLC/MS/MS |
5 |
|
95 |
Escitalopram |
HPLC/MS/MS |
0,25 |
|
96 |
Esomeprazole |
HPLC/MS/MS |
10 |
|
97 |
Estradiol |
HPLC/MS/MS |
0,0008 |
determination of endogenous levels in postmenopausal women |
98 |
Estrone |
HPLC/MS/MS |
0,001 |
determination of endogenous levels in postmenopausal women |
99 |
Estrone sulfate |
HPLC/MS/MS |
0,01 |
determination of endogenous levels in postmenopausal women |
100 |
Eszopiclon |
HPLC/MS/MS |
0,25 |
|
101 |
Ethinylestradiol |
HPLC/MS/MS |
0,001 |
|
102 |
Ethylmethylhydroxypyridine |
HPLC/MS/MS |
0,25 |
|
103 |
Ethylmethylhydroxypyridine |
HPLC/MS/MS |
1 |
|
104 |
Etoricoxib |
HPLC/MS/MS |
5 |
|
105 |
Everolimus |
HPLC/MS/MS |
1 |
in whole blood |
106 |
Exemestane |
HPLC/MS/MS |
0,25 |
|
107 |
Ezetimibe |
HPLC/MS/MS |
0,04 |
common method with ezetimibe glucuronide |
108 |
Ezetimibe |
HPLC/MS/MS |
0,08 |
common method with atorvastatin |
109 |
Ezetimibe |
HPLC/MS/MS |
0,05 |
common method with simvastatin |
110 |
Ezetimibe |
HPLC/MS/MS |
0,05 |
common method with atorvastatin and ezetimibe glucuronide |
111 |
Ezetimibe glucuronide |
HPLC/MS/MS |
1 |
common method with atorvastarin and ezetimibe |
112 |
Ezetimibe glucuronide |
HPLC/MS/MS |
0,8 |
common method with ezetimibe |
113 |
Ezetimibe glucuronide |
HPLC/MS/MS |
0,8 |
common method with atorvastatin |
114 |
Famotidine |
HPLC |
2,5 |
|
115 |
Fenpiverinium |
HPLC/MS/MS |
0,03 |
common method with ketorolac and pitofenone |
116 |
Fenspiride |
HPLC/MS/MS |
1 |
|
117 |
Fenspiride |
HPLC/MS/MS |
1 |
|
118 |
Fingolimod |
HPLC/MS/MS |
0,01 |
in whole blood |
119 |
Fluoxetine |
GC/MS |
0,4 |
|
120 |
Flupirtine |
HPLC/MS/MS |
20 |
|
121 |
Flupirtine |
HPLC/MS/MS |
10 |
|
122 |
Flurbiprofen |
HPLC/MS/MS |
100 |
|
123 |
Fluvoxamine |
HPLC |
1,5 |
|
124 |
Fosfomycin |
HPLC/MS/MS |
500 |
|
125 |
Fulvestrant |
HPLC/MS/MS |
0,2 |
|
126 |
Furagin (Furazidine) |
HPLC/MS/MS |
2 |
|
127 |
Furagin (Furazidine) |
HPLC/MS/MS |
100 |
|
128 |
Ganciclovir |
HPLC/MS/MS |
50 |
|
129 |
Gentamicin |
HPLC/MS/MS |
|
in animals samples |
130 |
Glargine |
ELISA |
7,5 µU/mL |
|
131 |
Gliclazide |
HPLC/MS/MS |
20 |
|
132 |
Glimepiride |
HPLC/MS/MS |
1 |
|
133 |
Glucosamine |
HPLC/MS/MS |
10 |
|
134 |
Glycoursodeoxycholic acid |
HPLC/MS/MS |
20 |
endogenous compound |
135 |
Hydrochlorothiazide |
HPLC/MS/MS |
0,2 |
|
136 |
Hydrochlorothiazide |
HPLC/MS/MS |
0,5 |
|
137 |
Hydrocortisone |
HPLC/MS/MS |
10 |
endogenous compound |
138 |
Hydroxyurea |
HPLC/MS/MS |
250 |
|
139 |
Ibuprofen |
HPLC/MS/MS |
500 |
|
140 |
Ibuprofen |
HPLC/MS/MS |
250 |
|
141 |
Isoprinosine (DIP) |
HPLC/MS/MS |
10 |
|
142 |
Isoprinosine (PAcBA) |
HPLC/MS/MS |
50 |
|
143 |
Imatinib |
HPLC/MS/MS |
20 |
|
144 |
Indapamide |
HPLC/MS/MS |
1 |
in whole blood |
145 |
Insulin |
ELISA |
6,25 µU/mL |
|
146 |
Insulin |
ELISA |
12,5 µU/mL |
|
147 |
Insulin |
ELISA |
4 µU/mL |
|
148 |
Ipidacrine |
HPLC/MS/MS |
0,1 |
|
149 |
Irbesartan |
HPLC/MS/MS |
5 |
|
150 |
Isoprinosine (DIP) |
HPLC/MS/MS |
80 |
|
151 |
Isoprinosine (PAcBA) |
HPLC/MS/MS |
200 |
|
152 |
Ivabradine |
HPLC/MS/MS |
0,25 |
|
153 |
Ketorolac |
HPLC/MS/MS |
3 |
common method with fenpiverinium and pitofenone |
154 |
Ketorolac |
HPLC/MS/MS |
30 |
|
155 |
Lacidipine |
HPLC/MS/MS |
0,02 |
|
156 |
Lenalidomide |
HPLC/MS/MS |
2 |
|
157 |
Letrozole |
HPLC/MS/MS |
0,5 |
|
158 |
Letrozole |
HPLC/MS/MS |
1 |
|
159 |
Levetiracetam |
HPLC/MS/MS |
200 |
|
160 |
Levocetirizine |
HPLC/MS/MS |
2,5 |
|
161 |
Levocetirizine |
HPLC/MS/MS |
1 |
common method with montelucast |
162 |
Levofloxacine |
HPLC/MS/MS |
100 |
|
163 |
Levothyroxine |
HPLC/MS/MS |
10 |
endogenous compound |
164 |
Linagliptin |
HPLC/MS/MS |
0,1 |
common method with dapagliflozin |
165 |
Linezolid |
HPLC/MS/MS |
200 |
|
166 |
Liothyronine |
HPLC/MS/MS |
0,25 |
endogenous compound |
167 |
Lisinopril |
HPLC/MS/MS |
1 |
|
168 |
Lornoxicam |
HPLC/MS/MS |
20 |
|
169 |
Losartan |
HPLC/MS/MS |
3 |
|
170 |
Lovastatin |
GC/MS/MS |
0,15 |
|
171 |
Lovastatin hydroxyacid |
GC/MS/MS |
0,15 |
|
172 |
Mebeverine acid |
HPLC/MS/MS |
10 |
|
173 |
Mebeverine acid, desmethyl |
HPLC/MS/MS |
10 |
|
174 |
Megestrol acetate |
HPLC/MS/MS |
1 |
|
175 |
Meldonium |
HPLC/MS/MS |
100 |
|
176 |
Meloxicam |
HPLC |
30 |
|
177 |
Meloxicam |
HPLC/MS/MS |
20 |
|
178 |
Memantine |
HPLC/MS/MS |
0,2 |
|
179 |
Metformin |
HPLC/MS/MS |
10 |
|
180 |
Methyldopa |
HPLC/MS/MS |
20 |
|
181 |
Methylsulfoxyethanol (MSE) |
HPLC/MS/MS |
200 |
|
182 |
Metoprolol |
HPLC/MS/MS |
1 |
|
183 |
Metronidazole |
HPLC/MS/MS |
20 |
|
184 |
Mianserin |
chiral HPLC/MS/MS |
0,2 |
|
185 |
Micophenolic acid |
HPLC/MS/MS |
500 |
|
186 |
Mildronate |
HPLC/MS/MS |
50 |
|
187 |
Milnacipran |
HPLC/MS/MS |
2 |
|
188 |
Misoprostol acid |
HPLC/MS/MS |
0,05 |
|
189 |
Misoprostol acid |
HPLC/MS/MS |
0,025 |
|
190 |
Moclobemide |
HPLC |
30 |
|
191 |
Montelukast |
HPLC/MS/MS |
1 |
|
192 |
Montelukast |
HPLC/MS/MS |
2 |
common method with levocetirizine |
193 |
Moxifloxacin |
HPLC/MS/MS |
50 |
|
194 |
Moxonidine |
HPLC/MS/MS |
0,02 |
|
195 |
N,N-Didesmethyl Sibutramine |
HPLC/MS/MS |
0,1 |
common method with N-desmethyl sibutramine and sibutramine |
196 |
N-Desmethyl Sibutramine |
HPLC/MS/MS |
0,1 |
common method with N,N-Didesmethyl sibutramine and sibutramine |
197 |
Naftidrofuryl |
HPLC |
200 |
|
198 |
Naproxen |
HPLC/MS/MS |
200 |
|
199 |
Naproxen |
HPLC/MS/MS |
10 |
in urine |
200 |
Naproxen |
HPLC/MS/MS |
500 |
|
201 |
Nebivolol |
HPLC/MS/MS |
0,02 |
|
202 |
Nerofe |
HPLC/MS/MS |
1 000,00 |
in dog plasma |
203 |
Nevirapine |
HPLC/MS/MS |
25 |
|
204 |
Nitrofurantoin |
HPLC/MS/MS |
2 |
|
205 |
Norgestimate |
HPLC/MS/MS |
0,0004 |
|
206 |
O-desmethyltramadol |
HPLC/MS/MS |
0,5 |
|
207 |
O-desmethylvenlafaxine |
HPLC/MS/MS |
0,5 |
|
208 |
O-hydroxy atorvastatin |
HPLC/MS/MS |
0,4 |
common method with ezetimibe |
209 |
Olanzapine |
HPLC/MS/MS |
0,1 |
|
210 |
Olanzapine |
HPLC/MS/MS |
0,25 |
|
211 |
Olmesartan |
HPLC/MS/MS |
10 |
|
212 |
Omeprazole |
HPLC/MS/MS |
10 |
|
213 |
Ondansetron |
HPLC/MS/MS |
1 |
|
214 |
Oracin |
HPLC |
20 |
|
215 |
Ornidazole |
HPLC/MS/MS |
200 |
|
216 |
Oseltamivir |
HPLC/MS/MS |
0,5 |
|
217 |
Oxybutynin |
GC/MS |
0,2 |
|
218 |
Paliperidon |
HPLC/MS/MS |
0,2 |
|
219 |
Paraxantine |
HPLC/MS/MS |
100 |
common method with caffeine |
220 |
Paroxetine |
HPLC/MS/MS |
0,1 |
|
221 |
Paroxetine |
HPLC/MS/MS |
0,025 |
|
222 |
Paroxetine metabolite |
HPLC/MS/MS |
0,2 |
|
223 |
Pentoxifylline |
HPLC/MS/MS |
1 |
|
224 |
Pentoxifylline metabolite M1 |
HPLC/MS/MS |
2 |
|
225 |
Pentoxifylline metabolite M5 |
HPLC/MS/MS |
10 |
|
226 |
Perindopril |
HPLC/MS/MS |
2,5 |
|
227 |
Perindoprilate |
HPLC/MS/MS |
0,25 |
|
228 |
p-hydroxy atorvastatin |
HPLC/MS/MS |
0,04 |
common method with ezetimibe |
229 |
Pioglitazone |
HPLC/MS/MS |
10 |
|
230 |
Pioglitazone metabolite M IV |
HPLC/MS/MS |
5 |
|
231 |
Piracetam |
HPLC/MS/MS |
500 |
|
232 |
Pitofenone |
HPLC/MS/MS |
1 |
common method with ketorolac and fenpiverinium |
233 |
Pizotifen |
GC/MS/MS |
0,05 |
|
234 |
Pramipexole |
HPLC/MS/MS |
0,02 |
|
235 |
Pramipexole |
HPLC/MS/MS |
0,01 |
|
236 |
Prednisolone |
HPLC/MS/MS |
3 |
|
237 |
Pregabalin |
HPLC/MS/MS |
50 |
|
238 |
Pridinol |
HPLC/MS/MS |
0,2 |
|
239 |
Pridinol |
HPLC/MS/MS |
1 |
in urine |
240 |
Propafenone |
HPLC/MS/MS |
1 |
|
241 |
Propiverine |
HPLC/MS/MS |
0,5 |
|
242 |
Quetiapine |
HPLC/MS/MS |
1 |
|
243 |
Raloxifene |
HPLC/MS/MS |
0,01 |
|
244 |
Raloxifene-4-glucoronide |
HPLC/MS/MS |
1 |
|
245 |
Raloxifene-6-glucoronide |
HPLC/MS/MS |
0,5 |
|
246 |
Ramipril |
HPLC/MS/MS |
0,2 |
|
247 |
Ramipril |
HPLC/MS/MS |
0,4 |
|
248 |
Ramipril |
HPLC/MS/MS |
0,05 |
in dog plasma |
249 |
Ramiprilate |
HPLC/MS/MS |
0,2 |
|
250 |
Ramiprilate |
HPLC/MS/MS |
0,5 |
in dog plasma |
251 |
Ranitidin |
HPLC |
10 |
|
252 |
Ranolazine |
HPLC/MS/MS |
25 |
|
253 |
Rasagiline |
HPLC/MS/MS |
0,1 |
|
254 |
Rebamipide |
HPLC/MS/MS |
4 |
|
255 |
Ribavirin |
HPLC/MS/MS |
3 |
|
256 |
Risperidone |
HPLC/MS/MS |
0,1 |
|
257 |
Ritonavir |
HPLC/MS/MS |
20 |
|
258 |
Rizatriptan |
HPLC/MS/MS |
0,1 |
|
259 |
Ropinirole |
HPLC/MS/MS |
0,1 |
|
260 |
Rosuvastatin |
HPLC/MS/MS |
0,05 |
|
261 |
Salicylic acid |
HPLC |
200 |
|
262 |
Salicylic acid |
HPLC/MS/MS |
100 |
common method with acetylsalicylic acid |
263 |
Salicylic acid |
HPLC/MS/MS |
20 |
common method with acetylsalicylic acid |
264 |
Sibutramine |
HPLC/MS/MS |
0,1 |
common method with N,N-didesmethyl sibutramine and N-desmethyl sibutramine |
265 |
Sildenafil |
HPLC/MS/MS |
1 |
|
266 |
Sildenafil |
HPLC/MS/MS |
5 |
|
267 |
Simvastatin |
GC/MS/MS |
0,5 |
|
268 |
Simvastatin |
LC/MS/MS |
0,5 |
|
269 |
Simvastatin |
LC/MS/MS |
0,2 |
common method with ezetimibe |
270 |
Simvastatin |
LC/MS/MS |
0,2 |
|
271 |
Simvastatin hydroxyacid |
GC/MS/MS |
0,1 |
|
272 |
Simvastatin hydroxyacid |
LC/MS/MS |
0,1 |
|
273 |
Simvastatin hydroxyacid |
LC/MS/MS |
0,05 |
common method with ezetimibe |
274 |
Sitagliptin |
HPLC/MS/MS |
1 |
|
275 |
Solifenacin |
HPLC/MS/MS |
0,2 |
|
276 |
Tadalafil |
HPLC/MS/MS |
5 |
|
277 |
Tamsulosin |
HPLC/MS/MS |
0,2 |
|
278 |
Tamsulosin |
HPLC/MS/MS |
0,1 |
|
279 |
Tamsulosin |
HPLC/MS/MS |
0,05 |
|
280 |
Tauroursodeoxycholic acid |
HPLC/MS/MS |
5 |
endogenous compound |
281 |
Telmisartan |
HPLC/MS/MS |
2 |
|
282 |
Tenofovir |
HPLC/MS/MS |
5 |
|
283 |
Terbinafine |
HPLC |
20 |
|
284 |
Thiocolchicoside metabolite M1 |
HPLC/MS/MS |
1 |
|
285 |
Tianeptine |
chiral HPLC/MS/MS |
2 |
|
286 |
Ticagrelor |
HPLC/MS/MS |
5 |
|
287 |
Tiotropium |
HPLC/MS/MS |
0,0001 |
|
288 |
Tolperisone |
HPLC/MS/MS |
0,5 |
|
289 |
Tolterodine |
HPLC/MS/MS |
0,05 |
|
290 |
Torasemide |
HPLC/MS/MS |
20 |
|
291 |
Toremifene |
HPLC/MS/MS |
2 |
|
292 |
Tramadol |
GC/MS |
6 |
|
293 |
Tramadol |
HPLC/MS/MS |
5 |
|
294 |
Trimetazidine |
HPLC/MS/MS |
0,5 |
|
295 |
Ulipristal |
HPLC/MS/MS |
0,2 |
|
296 |
Uridine |
HPLC/MS/MS |
150 |
endogenous compound |
297 |
Ursodeoxycholic acid |
HPLC/MS/MS |
10 |
endogenous compound |
298 |
Valganciclovir |
HPLC/MS/MS |
5 |
|
299 |
Valproic acid |
HPLC/MS/MS |
250 |
|
300 |
Valsartan |
HPLC/MS/MS |
50 |
|
301 |
Vardenafil |
HPLC/MS/MS |
0,25 |
|
302 |
Venlafaxine |
HPLC/MS/MS |
10 |
in rat plasma |
303 |
Venlafaxine |
HPLC/MS/MS |
0,5 |
|
304 |
Vildagliptin |
HPLC/MS/MS |
2 |
|
305 |
Voriconazole |
HPLC/MS/MS |
5 |
|
306 |
Warfarin |
HPLC |
20 |
|
307 |
Zidovudine |
HPLC/MS/MS |
25 |
|
308 |
Zolpidem |
HPLC |
1 |
plasma direct injection |
309 |
Zopiclon |
HPLC |
4 |
|